title: Treatment of a patient in a relapse after bone marrow transplantation for acute lymphoblastic leukemia with the systemic administration of allogeneic lymphokine-activated killer cells and recombinant interleukin-2.
authors: T
authors: T
authors: Komori
authors: H
authors: H
authors: Sugiyama
authors: H
authors: H
authors: Ogawa
authors: Y
authors: Y
authors: Oka
authors: S
authors: S
authors: Miyake
authors: T
authors: T
authors: Soma
authors: Y
authors: Y
authors: Tani
authors: Y
authors: Y
authors: Minami
authors: K
authors: K
authors: Kunisada
authors: T
authors: T
authors: Masaoka
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012008:Recurrence
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins; D007770:L-Lactate Dehydrogenase